Grace Meng

M

Senators Demand Mylan Lower Cost Of Life-Saving Epipens, Call For Congressional Hearing

The cost of a life-saving EpiPen from drug maker Mylan increased as much as 600% in just nine years. That’s simply too much, lawmakers say, with some legislators now calling on the pharmaceutical giant to drop its price immediately, while others are pushing for a congressional hearing on the matter.  [More]